EPTIS
BAM Logo

Forensic Blood Toxicology Scheme - (QUARTZ)

EPTIS factsheet 132699 | Last revision 2018-01-23 | URL: https://www.eptis.bam.de/pts132699 https://www.eptis.bam.de/pts132699

PT provider
PT provider LGC Standards Proficiency Testing LGC Standards Proficiency Testing
Based in United Kingdom
Language(s)
Remarks
Keywords
Product groups Human test material
Laboratory / scientific equipment
Pharmaceutical products, drugs
Testing fields Analytical chemistry
Medical analysis
Technical details
Test item Tested property Testing method
Alcohol technical defence - ATD Blood and breath alcohol concentrations (Paper exercise) -
Forensic toxicology drugs (Blood) Forensic toxicology drugs -
Carboxyhaemoglobin -
Barbiturates -
Benzodiazepines -
Cannabinoids -
Anaesthetics -
Anticholinergics -
Anticonvulsants -
Antidepressants -
Antihistamines -
Antipsychotics -
Cardiovascular drugs -
Erectile dysfunction -
Hypnotic drugs -
Non steroidal anti-Inflammatory analgesics -
Opioid analgesics -
Stimulants -
Forensic toxicology drugs (Blood and case study) Carboxyhaemoglobin -
Barbiturates -
Benzodiazepines -
Cannabinoids -
Anticholinergics -
Anticonvulsants -
Antidepressants -
Antihistamines -
Antipsychotics -
Cardiovascular drugs -
Erectile dysfunction -
Hypnotic drugs -
Non steroidal anti-Inflammatory analgesics -
Opioid analgesics -
Stimulants -
Abuse drugs (Blood) Methadone Quantitative assay
Morphine -
Diazepam -
Amphetamine -
Prescribed drugs (Blood) Amitriptyline -
Citalopram -
Codeine -
Tramadol -
New psychoactive substances (Blood) Samples contain analytes which are pre-defined by our Advisory Group and the request of participants Quantitative assay
2-CB -
3-Fluorophenmetrazine -
Diclazepam -
PMMA -
Driving impairment- Alcohol (Blood) Fluoride -
Ethanol -
Blood A blood sample containing a synthetic cannabinoid. Participants are asked to screen for synthetic cannabinoids and identify one of the most common synthetic cannabinoids Qualitative analysis
Urine Identify up to 4 drugs or metabolites relevant to forensic toxicology Identification
Urine- New psychoactive and synthetic cannabinoid A urine sample specifically for New Psychoactive Substance screening and may include synthetic cannabinoids. Up to two substances may be present. No interpretation is required. Identification
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party

Accredited by UKAS on the basis of ISO/IEC 17043 Please see current application form and scheme description for accredited and non-accredited status of test materials and analytes.

Operation is commissioned / requested by
Fees and frequency
Participation fee Depending on samples taken
Regularly operated Yes (4 rounds per annum)
Year of first operation April 2000
Contact details of the PT provider
Provider Contact person
LGC Standards Proficiency Testing
1 Chamberhall Business Park, Chamberhall Green,
BL9 0AP Bury Lancashire
United Kingdom

Phone: +44 (0)161 762 2500
Fax: +44 (0)161 762 2501
Web: http://www.lgcstandards.com http://www.lgcstandards.com
Mr Savvas Xystouris
Phone: +44 (0)161 762 2500
Fax: +44 (0)161 762 2501
Email: savvas.xystouris@lgcgroup.com savvas.xystouris@lgcgroup.com
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21